Prism Medico and Pharmacy Limited (BOM:512217)
29.65
+0.50 (1.72%)
At close: Aug 21, 2026
Prism Medico and Pharmacy Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 1, 2022 |
Cash & Equivalents | - | 0.64 | 0.65 | 0.84 | 0.96 | 0.55 |
Cash & Short-Term Investments | 0.64 | 0.64 | 0.65 | 0.84 | 0.96 | 0.55 |
Cash Growth | -2.60% | -2.60% | -21.77% | -12.64% | 73.68% | -34.51% |
Accounts Receivable | - | 39.33 | 35.84 | 36.9 | 47.61 | 48.81 |
Other Receivables | - | 29.72 | 29.98 | 29.77 | - | - |
Receivables | - | 75.65 | 71.42 | 72.26 | 82.74 | 54.8 |
Inventory | - | 67.71 | 67.71 | 67.71 | 67.71 | 67.71 |
Other Current Assets | - | 10.6 | 12.9 | 9.09 | 0.01 | 0.34 |
Total Current Assets | - | 154.6 | 152.68 | 149.89 | 151.41 | 123.39 |
Property, Plant & Equipment | - | 0.26 | 0.29 | 0.34 | 0.39 | 0.45 |
Long-Term Deferred Tax Assets | - | 1.26 | 2.37 | 2.2 | 2.14 | 1.88 |
Other Long-Term Assets | - | 0 | 0.3 | 0 | 0 | -0 |
Total Assets | - | 156.11 | 155.65 | 152.43 | 153.93 | 125.72 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 1, 2022 |
Accounts Payable | - | 1.24 | - | 0.31 | - | - |
Accrued Expenses | - | 0.08 | 0.05 | 0.05 | - | - |
Other Current Liabilities | - | 0.69 | 4.67 | 0.66 | 2.32 | 0.17 |
Total Current Liabilities | - | 2 | 4.72 | 1.02 | 2.32 | 0.17 |
Other Long-Term Liabilities | - | 0 | 0 | 0 | - | - |
Total Liabilities | - | 2 | 4.72 | 1.02 | 2.32 | 0.17 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 1, 2022 |
Common Stock | - | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 |
Retained Earnings | - | 93.48 | 90.29 | 90.78 | 90.98 | 64.91 |
Shareholders' Equity | 154.11 | 154.11 | 150.93 | 151.42 | 151.62 | 125.55 |
Total Liabilities & Equity | - | 156.11 | 155.65 | 152.43 | 153.93 | 125.72 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 1, 2022 |
Net Cash (Debt) | 0.64 | 0.64 | 0.65 | 0.84 | 0.96 | 0.55 |
Net Cash Growth | -2.60% | -2.60% | -21.77% | -12.64% | 73.68% | -34.51% |
Net Cash Per Share | 0.04 | 0.11 | 0.11 | 0.14 | 0.16 | 0.09 |
Filing Date Shares Outstanding | 14.58 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 |
Total Common Shares Outstanding | 14.58 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 |
Working Capital | - | 152.6 | 147.97 | 148.88 | 149.09 | 123.22 |
Book Value Per Share | 25.42 | 25.42 | 24.89 | 24.97 | 25.00 | 20.71 |
Tangible Book Value | 154.11 | 154.11 | 150.93 | 151.42 | 151.62 | 125.55 |
Tangible Book Value Per Share | 25.42 | 25.42 | 24.89 | 24.97 | 25.00 | 20.71 |
Machinery | - | 2.2 | - | - | - | - |